Medicine Description oxytocin-minapharm 5i
Oxytocin Minapharm is a medication primarily known for its role in facilitating childbirth and managing postpartum conditions. It exerts its effects by binding to specific G-protein coupled receptors located in target tissues, predominantly the uterus and mammary glands. Upon binding, oxytocin activates the Gq and G11 protein pathways, leading to the stimulation of phospholipase C. This enzymatic action results in the hydrolysis of phosphatidylinositol-4,5-bisphosphate, producing inositol triphosphate (IP3) and diacylglycerol (DAG). The production of IP3 leads to the release of calcium ions from intracellular stores, significantly increasing the cytosolic calcium concentration. This influx of calcium is a key trigger for uterine smooth muscle contraction. Additionally, oxytocin promotes the synthesis of prostaglandins, further enhancing uterine contractility, thus facilitating labor and delivery.
Indications and Uses of Oxytocin Minapharm
- Induction of labor
- Augmentation of labor
- Management of postpartum hemorrhage
- Induction of abortion
- Oxytocin challenge test
Side Effects of Oxytocin Minapharm
- Uterine hyperstimulation
- Cardiovascular changes
- Nausea and vomiting
- Water retention and hyponatremia
- Allergic reactions
Storage and Handling
Store Oxytocin Minapharm at room temperature, away from light and moisture. Do not freeze and ensure the vial is tightly closed when not in use.
Patient Advice and Precautions
Patients should be monitored closely for uterine contractions and fetal heart rate during administration. It is crucial to ensure proper hydration and to be aware of signs of uterine hyperstimulation. Discuss any allergies or previous reactions to oxytocin with healthcare providers before starting treatment.